![](https://fibiomed.com/wp-content/uploads/2021/07/1_loga_-_wspolfinansowane_ze_srodkow_UE-1.jpg)
![](https://fibiomed.com/wp-content/uploads/2021/07/2_loga_-_wspolfinansowane_ze_srodkow_UE-1.jpg)
FIBIOMED SPFIBIOMED SPÓŁKA z o.o. (LLC) is undertaking the project titled
Development and testing of an innovative technology to cultivate specific antibodies, and a device for fast diagnostics of viruses (including SARS-Cov-2) that can be implemented in the diagnostics, treatment and prevention during states of epidemiological emergency, as part of Measure 1.1 “R+D Projects of Enterprises” and Sub-Measure 1.1.1 “Industrial Research and Development Works Conducted by Enterprises”
The objective of the project is to develop, test and implement an innovative partly automated device for high-throughput analysis of samples for SARS-CoV-2 that can be easily and quickly adapted to the analysis of other pathogens or diagnostic markers.
Project value: PLN 12,327,736.88
Contribution of European Funds: PLN 10,046,456.53